Abstract
The first synthesis of 1'-cyano-2'-C-methyl pyrimidine nucleosides is described. Anti-HCV activity of these nucleosides and their nucleotide phosphoramidate prodrugs was assessed and compared to the 1'-unsubstituted counterparts and to the related 1'-cyano-2'-C-methyl C-nucleoside parent of GS-6620.
Keywords:
HCV antivirals; NS5B polymerase inhibitor; Nucleotide phosphoramidate prodrugs; Pyrimidine nucleoside analogs.
Copyright © 2014 Elsevier Ltd. All rights reserved.
MeSH terms
-
Antiviral Agents / chemical synthesis
-
Antiviral Agents / chemistry
-
Antiviral Agents / pharmacology*
-
Dose-Response Relationship, Drug
-
Enzyme Inhibitors / chemical synthesis
-
Enzyme Inhibitors / chemistry
-
Enzyme Inhibitors / pharmacology*
-
Hepacivirus / drug effects*
-
Hepacivirus / enzymology*
-
Microbial Sensitivity Tests
-
Molecular Conformation
-
Nucleosides / chemical synthesis
-
Nucleosides / chemistry
-
Nucleosides / pharmacology*
-
Pyrimidine Nucleosides / chemical synthesis
-
Pyrimidine Nucleosides / chemistry
-
Pyrimidine Nucleosides / pharmacology*
-
RNA-Dependent RNA Polymerase / antagonists & inhibitors*
-
RNA-Dependent RNA Polymerase / metabolism
-
Structure-Activity Relationship
-
Viral Nonstructural Proteins / antagonists & inhibitors*
-
Viral Nonstructural Proteins / metabolism
Substances
-
Antiviral Agents
-
Enzyme Inhibitors
-
Nucleosides
-
Pyrimidine Nucleosides
-
Viral Nonstructural Proteins
-
NS-5 protein, hepatitis C virus
-
RNA-Dependent RNA Polymerase